Medical imaging can assess the tumor and its environment in their entirety, which makes it
suitable for monitoring the temporal and spatial characteristics of the tumor. Progress in …

Tumor budding is a well-established independent prognostic factor in colorectal cancer but
a standardized method for its assessment has been lacking. The primary aim of the …

The American Society of Colon and Rectal Surgeons (ASCRS) is dedicated to ensuring high-
quality patient care by advancing the science, prevention, and management of disorders …

Purpose: To develop and validate a radiomics model for evaluating pathologic complete
response (pCR) to neoadjuvant chemoradiotherapy in patients with locally advanced rectal …

Background Induction of a clinical complete response with chemoradiotherapy, followed by
observation via a watch-and-wait approach, has emerged as a management option for …

Background: Systemic inflammation via host-tumor interactions is currently recognized as a
hallmark of cancer. The aim of this study was to evaluate the prognostic value of various …

Purpose: To evaluate multiparametric MRI features in predicting pathologic response after
preoperative chemoradiation therapy (CRT) for locally advanced rectal cancer (LARC) …

Background The role of adjuvant chemotherapy for patients with rectal cancer is
controversial, especially when used after preoperative chemoradiotherapy. Fluoropyrimidine …

Tumor budding is an important additional prognostic factor for patients with colorectal cancer
(CRC). Defined as the presence of single tumor cells or small clusters of up to 5 cells in the …

Objectives To investigate whether CT-based radiomics signature can predict
KRAS/NRAS/BRAF mutations in colorectal cancer (CRC). Methods This retrospective study …